A double-blind, placebo-controlled, crossover, exploratory study assessing the effects of a single low oral dose of psilocybin in migraine headache
Latest Information Update: 14 Jul 2020
At a glance
- Drugs Psilocybin (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 14 Jul 2020 New trial record
- 20 Jun 2020 Interim results presented at the 62nd Annual Scientific Meeting of the American Headache Society